第二剂mRNA新冠疫苗接种后酷似急性冠状动脉综合征的急性心肌心包炎

Pantsios Chris, Anyfantakis Zacharias-Alexandros, Xanthopoulos Andrew, Leventis Ioannis, Skoularigkis Spyridon, Dimos Apostolos, Bourazana Angeliki, Papamichalis Michail, Giamouzis Grigorios, Triposkiadis Filippos, Skoularigis John

Department of Cardiology, General University Hospital of Larissa, Larissa, Greece.

Case Rep Cardiol. 2022 Aug 9;2022:1600734. doi: 10.1155/2022/1600734. eCollection 2022.

Myocarditis is a rare adverse event of vaccination. Recently, mRNA vaccines for COVID-19 have been reported to correlate with myocarditis, specifically in adolescents and young men. We report a rare case of a 50-year-old man who presented with symptoms of myocardial infarction 3 days after the second dose of vaccination for COVID-19. Cardiac magnetic resonance (CMR) imaging revealed acute myopericarditis. Clinicians should be aware of that rare side effect of mRNA vaccines for COVID-19 that can affect not only younger recipients but also middle-aged patients presenting with symptoms mimicking acute coronary syndrome.

心肌炎是一种罕见的疫苗接种不良事件。最近，有报道称新冠病毒mRNA疫苗与心肌炎有关，特别是在青少年和年轻男性中。我们报告了一例罕见病例，一名50岁男性在接种第二剂新冠病毒疫苗3天后出现心肌梗死症状。心脏磁共振成像显示为急性心肌心包炎。临床医生应意识到新冠病毒mRNA疫苗的这种罕见副作用，它不仅会影响年轻接种者，还会影响表现出类似急性冠状动脉综合征症状的中年患者。